Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type (1 selected)

Type

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 1101 to 1150 of 2047

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancerHTG487
Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemiaTA541
Preventing suicide in community and custodial settingsNG105
Superior rectal artery embolisation for haemorrhoidsHTG485
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumoursTA539
Sutureless aortic valve replacement for aortic stenosisHTG483
Dinutuximab beta for treating neuroblastomaTA538
Flu vaccination: increasing uptakeNG103
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaHTG482
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA537
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodineTA535
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Community pharmacies: promoting health and wellbeingNG102
Dupilumab for treating moderate to severe atopic dermatitisTA534
Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healingHTG480
Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fracturesHTG481
Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healingHTG479
Superior capsular augmentation for massive rotator cuff tearsHTG477
Transaxial interbody lumbosacral fusion for severe chronic low back painHTG478
Ocrelizumab for treating relapsing–remitting multiple sclerosisTA533
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancerTA531
Biomarker tests to help diagnose preterm labour in women with intact membranesHTG476
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapyTA530
Beta interferons and glatiramer acetate for treating multiple sclerosisTA527
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremorHTG474
Laparoscopic ventral mesh rectopexy for internal rectal prolapseHTG475
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's diseaseTA217
Dementia: assessment, management and support for people living with dementia and their carersNG97
Intranasal phototherapy for allergic rhinitisHTG473
Guselkumab for treating moderate to severe plaque psoriasisTA521
Midostaurin for untreated acute myeloid leukaemiaTA523
Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaTA524
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA525
Arsenic trioxide for treating acute promyelocytic leukaemiaTA526
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 or overNG36
Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapyHTG472
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapyTA520
Percutaneous balloon valvuloplasty for fetal critical aortic stenosisHTG471
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan IHTG467
Robot-assisted kidney transplantHTG468
Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasiaHTG469
Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucomaHTG470
Nerve transfer to partially restore upper limb function in tetraplegiaHTG466
Tocilizumab for treating giant cell arteritisTA518
Care and support of people growing older with learning disabilitiesNG96
Cabozantinib for treating medullary thyroid cancerTA516
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimenTA515
Learning disabilities and behaviour that challenges: service design and deliveryNG93
Emergency and acute medical care in over 16s: service delivery and organisationNG94
Physical activity and the environmentNG90

Results per page

  1. 10
  2. 25
  3. 50
  4. All